Natus Medical Inc  

(Public, NASDAQ:BABY)   Watch this stock  
Find more results for BABY
-0.37 (-1.02%)
Jan 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 36.04 - 36.60
52 week 21.54 - 39.12
Open 36.39
Vol / Avg. 317,760.00/215,820.00
Mkt cap 1.17B
P/E 37.65
Div/yield     -
EPS 0.96
Shares 32.55M
Beta 1.01
Inst. own 90%
Jan 28, 2015
Q4 2014 Natus Medical Inc Earnings Call - 11:00AM EST - Add to calendar
Jan 28, 2015
Q4 2014 Natus Medical Inc Earnings Release - 9:30AM EST - Add to calendar
Jan 15, 2015
Natus Medical Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 8.66% 6.65%
Operating margin 14.20% 9.96%
EBITD margin - 15.50%
Return on average assets 7.48% 5.59%
Return on average equity 9.43% 7.96%
Employees 943 -
CDP Score - -


6701 Koll Center Pkwy Ste 120
PLEASANTON, CA 94566-8061
United States - Map
+1-925-2236700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Natus Medical Incorporated is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company�s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn�s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. Its product categories include Hearing, Neurology and Newborn Care. It owns Embla Systems LLC and the Nicolet neurodiagnostic business. It also provides a system of IP cameras, secure mobile viewing links, and a service program.

Officers and directors

Robert A. Gunst Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James B. Hawkins President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jonathan A. Kennedy Chief Financial Officer, Senior Vice President
Age: 43
Bio & Compensation  - Reuters
Austin F. Noll III Vice President and General Manager - Neurology Strategic Business Unit
Bio & Compensation  - Reuters
Kenneth M. Traverso Vice President, General Manager - Newborn Care Strategic Business Unit
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ajay A. Bhave Vice President - Global Engineering
Age: 57
Bio & Compensation  - Reuters
D. Christopher Chung M.D. Vice President - Medical Affairs, Quality & Regulatory
Age: 50
Bio & Compensation  - Reuters
Doris E. Engibous Independent Director
Age: 59
Bio & Compensation  - Reuters
Kenneth E. Ludlum Independent Director
Age: 60
Bio & Compensation  - Reuters
William M. Moore Jr. Independent Director
Age: 65
Bio & Compensation  - Reuters